Effect of a web-based relapse prevention program on abstinence among Japanese drug users: A pilot randomized controlled trial

Ayumi Takano, Yuki Miyamoto, Tomohiro Shinozaki, Toshihiko Matsumoto, Norito Kawakami

Research output: Contribution to journalArticle

Abstract

Background: Internet-based intervention could help drug users recover from drug dependence. This study evaluated the effectiveness of a newly developed web-based relapse prevention program (e-SMARPP) for people with a drug problem, including the use of methamphetamine, in Japan. Methods: The study was a pilot randomized controlled trial comprised of 48 psychiatric outpatients diagnosed with drug use disorder. The participants were randomly assigned to an eight-week, six-session web-based relapse prevention program (an intervention group) or only web-based self-monitoring (a control group). The primary outcome was the duration of abstinence from a primary drug during the intervention and relapse risk. Secondary outcomes included motivation to change, self-efficacy, and money spent on drugs. The outcomes, except for the duration of abstinence during the intervention, were assessed at baseline, 2-, 5-, and 8-months. Program completion rate was also assessed. Results: No significant difference was observed between the intervention and the control groups for the primary and the secondary outcomes. The effect size of the duration of abstinence during the intervention was d = 0.42, which was comparable to previous studies. In the intervention group, about 26% did not complete the entire intervention. Conclusions: e-SMARPP failed to demonstrate efficacy, however, is potentially helpful for enhancing abstinence. The low attrition rate may suggest the acceptance and feasibility of the program. Further improvement of the program and evaluation in a full-scale trial are needed.

Original languageEnglish
Pages (from-to)37-46
Number of pages10
JournalJournal of Substance Abuse Treatment
Volume111
DOIs
Publication statusPublished - Apr 2020

Fingerprint

Secondary Prevention
Drug Users
Randomized Controlled Trials
Substance-Related Disorders
Pharmaceutical Preparations
Control Groups
Methamphetamine
Program Evaluation
Self Efficacy
Internet
Psychiatry
Motivation
Japan
Outpatients
Recurrence

Keywords

  • Methamphetamine
  • Pilot study
  • Randomized controlled trial
  • Relapse prevention
  • Self-monitoring
  • Web-based intervention

Cite this

@article{7bcdd96eac694dab930835db6161cbf3,
title = "Effect of a web-based relapse prevention program on abstinence among Japanese drug users: A pilot randomized controlled trial",
abstract = "Background: Internet-based intervention could help drug users recover from drug dependence. This study evaluated the effectiveness of a newly developed web-based relapse prevention program (e-SMARPP) for people with a drug problem, including the use of methamphetamine, in Japan. Methods: The study was a pilot randomized controlled trial comprised of 48 psychiatric outpatients diagnosed with drug use disorder. The participants were randomly assigned to an eight-week, six-session web-based relapse prevention program (an intervention group) or only web-based self-monitoring (a control group). The primary outcome was the duration of abstinence from a primary drug during the intervention and relapse risk. Secondary outcomes included motivation to change, self-efficacy, and money spent on drugs. The outcomes, except for the duration of abstinence during the intervention, were assessed at baseline, 2-, 5-, and 8-months. Program completion rate was also assessed. Results: No significant difference was observed between the intervention and the control groups for the primary and the secondary outcomes. The effect size of the duration of abstinence during the intervention was d = 0.42, which was comparable to previous studies. In the intervention group, about 26{\%} did not complete the entire intervention. Conclusions: e-SMARPP failed to demonstrate efficacy, however, is potentially helpful for enhancing abstinence. The low attrition rate may suggest the acceptance and feasibility of the program. Further improvement of the program and evaluation in a full-scale trial are needed.",
keywords = "Methamphetamine, Pilot study, Randomized controlled trial, Relapse prevention, Self-monitoring, Web-based intervention",
author = "Ayumi Takano and Yuki Miyamoto and Tomohiro Shinozaki and Toshihiko Matsumoto and Norito Kawakami",
year = "2020",
month = "4",
doi = "10.1016/j.jsat.2019.12.001",
language = "English",
volume = "111",
pages = "37--46",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",

}

Effect of a web-based relapse prevention program on abstinence among Japanese drug users : A pilot randomized controlled trial. / Takano, Ayumi; Miyamoto, Yuki; Shinozaki, Tomohiro; Matsumoto, Toshihiko; Kawakami, Norito.

In: Journal of Substance Abuse Treatment, Vol. 111, 04.2020, p. 37-46.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of a web-based relapse prevention program on abstinence among Japanese drug users

T2 - A pilot randomized controlled trial

AU - Takano, Ayumi

AU - Miyamoto, Yuki

AU - Shinozaki, Tomohiro

AU - Matsumoto, Toshihiko

AU - Kawakami, Norito

PY - 2020/4

Y1 - 2020/4

N2 - Background: Internet-based intervention could help drug users recover from drug dependence. This study evaluated the effectiveness of a newly developed web-based relapse prevention program (e-SMARPP) for people with a drug problem, including the use of methamphetamine, in Japan. Methods: The study was a pilot randomized controlled trial comprised of 48 psychiatric outpatients diagnosed with drug use disorder. The participants were randomly assigned to an eight-week, six-session web-based relapse prevention program (an intervention group) or only web-based self-monitoring (a control group). The primary outcome was the duration of abstinence from a primary drug during the intervention and relapse risk. Secondary outcomes included motivation to change, self-efficacy, and money spent on drugs. The outcomes, except for the duration of abstinence during the intervention, were assessed at baseline, 2-, 5-, and 8-months. Program completion rate was also assessed. Results: No significant difference was observed between the intervention and the control groups for the primary and the secondary outcomes. The effect size of the duration of abstinence during the intervention was d = 0.42, which was comparable to previous studies. In the intervention group, about 26% did not complete the entire intervention. Conclusions: e-SMARPP failed to demonstrate efficacy, however, is potentially helpful for enhancing abstinence. The low attrition rate may suggest the acceptance and feasibility of the program. Further improvement of the program and evaluation in a full-scale trial are needed.

AB - Background: Internet-based intervention could help drug users recover from drug dependence. This study evaluated the effectiveness of a newly developed web-based relapse prevention program (e-SMARPP) for people with a drug problem, including the use of methamphetamine, in Japan. Methods: The study was a pilot randomized controlled trial comprised of 48 psychiatric outpatients diagnosed with drug use disorder. The participants were randomly assigned to an eight-week, six-session web-based relapse prevention program (an intervention group) or only web-based self-monitoring (a control group). The primary outcome was the duration of abstinence from a primary drug during the intervention and relapse risk. Secondary outcomes included motivation to change, self-efficacy, and money spent on drugs. The outcomes, except for the duration of abstinence during the intervention, were assessed at baseline, 2-, 5-, and 8-months. Program completion rate was also assessed. Results: No significant difference was observed between the intervention and the control groups for the primary and the secondary outcomes. The effect size of the duration of abstinence during the intervention was d = 0.42, which was comparable to previous studies. In the intervention group, about 26% did not complete the entire intervention. Conclusions: e-SMARPP failed to demonstrate efficacy, however, is potentially helpful for enhancing abstinence. The low attrition rate may suggest the acceptance and feasibility of the program. Further improvement of the program and evaluation in a full-scale trial are needed.

KW - Methamphetamine

KW - Pilot study

KW - Randomized controlled trial

KW - Relapse prevention

KW - Self-monitoring

KW - Web-based intervention

UR - http://www.scopus.com/inward/record.url?scp=85077748007&partnerID=8YFLogxK

U2 - 10.1016/j.jsat.2019.12.001

DO - 10.1016/j.jsat.2019.12.001

M3 - Article

AN - SCOPUS:85077748007

VL - 111

SP - 37

EP - 46

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

ER -